Treatment of Anemia of Chronic Disease with True Iron Deficiency in Pregnancy

Table 2

Hematological data, serum iron status, and serum EPO before and after treatment (, , and ).

	ACD + ID			IDA
	()			()
	Mean ± SD		value	Mean ± SD		value
	Before	After		Before	After
Hb (g/dl)		10.8 ± 0.7	0.001	9.1 ± 0.5	11.1 ± 0.5	0.001
RBC (×10^6/µl)		3.55 ± 0.21	0.002	3.67 ± 0.37	4.15 ± 0.37	0.001
HCT (%)		31.7 ± 2.0	0.001	28.0 ± 1.8	33.4 ± 2.0	0.001
Reticulocytes (%)		2.93 ± 0.56	0.036	2.42 ± 0.91	2.69 ± 0.92	0.247
MCV (fl)		89.4 ± 4.2	0.074	76.9 ± 5.6	80.9 ± 5.1	0.002
MCH (pg)		30.5 ± 1.2	0.089	24.9 ± 2.4	26.8 ± 2.1	0.001
MRC (%)		1.2 ± 1.0	0.286	8.7 ± 7.2	9.8 ± 6.3	0.477
HRC (%)		1.0 ± 1.1	0.948	12.4 ± 8.5	1.5 ± 0.9	0.001
CHr (pg)		33.8 ± 1.0	0.014	25.7 ± 1.2	32.5 ± 0.6	0.001
RDW (%)		15.8 ± 1.4	0.087	15.2 ± 0.7	19.8 ± 0.5	0.001
Iron (µmol/l)	12.6 ± 7.3	19.0 ± 4.4	0.094	7.2 ± 5.3	15.0 ± 5.5	0.001
Transferrin (μmol/l)	40.1 ± 10.5	34.2 ± 5.6	0.266	50.1 ± 11.3	42.9 ± 9.8	0.030
Ferritin (µg/l)	11.0 ± 4.6	177.5 ± 69.1	0.001	6.2 ± 2.8	126.0 ± 72.5	0.001
Transferrin saturation (%)	17.4 ± 12.5	27.7 ± 5.1	0.106	8.2 ± 7.1	18.7 ± 8.5	0.001
EPO (U/l)	42.1 ± 31.8	21.1 ± 5.9	0.087	94.7 ± 52.3	37.9 ± 22.1	0.001